Halox ES Ointment is a topical formulation containing Halobetasol propionate (0.05% w/w) and Salicylic Acid (6% w/w), indicated for the management of various inflammatory and hyperkeratotic dermatoses. Halobetasol, a potent corticosteroid, exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating the release of inflammatory mediators and suppressing immune responses within the skin. Salicylic Acid acts as a keratolytic agent, promoting the shedding of the stratum corneum and facilitating enhanced penetration of the corticosteroid. This combination is particularly effective in treating conditions such as psoriasis, eczema, lichen planus, and other hyperkeratotic disorders characterized by thickened, scaly plaques. Halox ES Ointment should be applied sparingly to the affected areas once or twice daily, as prescribed, and treatment duration should be limited to minimize potential adverse effects associated with potent corticosteroids, including skin atrophy, telangiectasia, and hypothalamic-pituitary-adrenal axis suppression. Caution is advised in patients with infections or hypersensitivity to any components. The ointment is contraindicated for use on the face, groin, or axillae unless directed by a healthcare professional. Regular monitoring and adherence to recommended usage guidelines are essential to ensure therapeutic efficacy and safety.